https://lgx818inhibitor.com/sp....erm-count-and-also-d
Further analysis revealed BSI was observed at frequencies from 17% to 60%, and a subsequent assessment found a prevalence in the range from 21% to 25%. Multivariate analysis identified prior intensive care unit (ICU) hospitalization, immunosuppressive therapy, and carbapenem exposure as independent contributors to CRPA BSI development. Of the 137 patients with CRPA BSI, 39% exhibited crude mortality within a 30-day period. The identific